Acadian Asset Management LLC Purchases Shares of 262,602 Avanos Medical, Inc. $AVNS

Acadian Asset Management LLC acquired a new stake in shares of Avanos Medical, Inc. (NYSE:AVNS) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 262,602 shares of the company’s stock, valued at approximately $3,212,000. Acadian Asset Management LLC owned approximately 0.57% of Avanos Medical as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. US Bancorp DE grew its holdings in Avanos Medical by 7.7% during the 1st quarter. US Bancorp DE now owns 15,184 shares of the company’s stock valued at $218,000 after buying an additional 1,091 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Avanos Medical by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,955 shares of the company’s stock valued at $386,000 after purchasing an additional 1,121 shares in the last quarter. State of Alaska Department of Revenue increased its position in Avanos Medical by 8.0% in the second quarter. State of Alaska Department of Revenue now owns 27,504 shares of the company’s stock worth $336,000 after purchasing an additional 2,039 shares during the last quarter. EP Wealth Advisors LLC raised its stake in Avanos Medical by 46.3% during the first quarter. EP Wealth Advisors LLC now owns 14,783 shares of the company’s stock valued at $212,000 after purchasing an additional 4,675 shares in the last quarter. Finally, State of Wyoming lifted its position in Avanos Medical by 104.6% during the first quarter. State of Wyoming now owns 10,508 shares of the company’s stock valued at $151,000 after purchasing an additional 5,371 shares during the last quarter. 95.17% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AVNS. Wall Street Zen upgraded shares of Avanos Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Zacks Research raised Avanos Medical to a “hold” rating in a research note on Tuesday, August 12th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Avanos Medical in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Avanos Medical has an average rating of “Reduce”.

Avanos Medical Trading Down 3.0%

NYSE AVNS opened at $11.39 on Friday. The stock has a market cap of $528.82 million, a PE ratio of -1.12 and a beta of 1.19. Avanos Medical, Inc. has a 12 month low of $9.30 and a 12 month high of $19.91. The company’s 50-day moving average price is $11.61 and its 200-day moving average price is $11.88. The company has a current ratio of 2.38, a quick ratio of 1.36 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.10. The company had revenue of $177.80 million during the quarter, compared to analysts’ expectations of $164.50 million. Avanos Medical had a negative net margin of 67.00% and a positive return on equity of 6.21%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.33 EPS. Avanos Medical has set its FY 2025 guidance at 0.850-0.950 EPS. Equities research analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.